Warrants

Venus Concept is raising capital through a registered direct offering. The company aims to raise $1.15 million initially by selling common stock at $2.65 per share, with an additional $2.3 million possible through warrants. The offering, which is expected to close around June 9, 2025, will provide funds for general corporate purposes. Venus Concept, a medical aesthetic technology provider in over 60 countries, offers a range of devices and is driven by investors in the healthcare industry.

Helius Medical Technologies has priced its public offering, offering 2,768,600 shares of Class A common stock equivalents with warrants for an additional 2,768,600 shares at $3.27 per unit. Warrants have a 2.5-year lifespan and an initial exercise price of $7.35. The offering is expected to close June 6, 2025, with gross proceeds of $9.1 million. Maxim Group LLC is the placement agent.